Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100 - Concepedia

Concepedia

Publication | Open Access

Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100

DOI Full Paper Access

212

Citations

26

References

2020

Year

Markus Moehler, Mikhail Dvorkin, Narikazu Boku, Mustafa Özgüroğlu, Min‐Hee Ryu, Alina Muntean, Sara Lonardi, Marina Nechaeva, Arinilda Campos Bragagnoli, Hasan Şenol Çoşkun,

Journal of Clinical Oncology

Abstract

JAVELIN Gastric 100 did not demonstrate superior OS with avelumab maintenance versus continued chemotherapy in patients with advanced GC or GEJC overall or in a prespecified PD-L1-positive population.

References

	Year	Citations

Page 1